Logo

nRichDx: Revolution System

Sep 27, 2019

nRichDx has launched its high-yield sample prep Revolution System. The Irvine, California firm designed the in vitro diagnostic system to increase liquid biopsy-based test sensitivity by delivering more target input for molecular assays. Researchers can currently use the platform to extract cell-free DNA from plasma and urine, followed by eventual applications for circulating tumor cells, exosomes, and total cell-free nucleic acid in the development pipeline. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.